{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:57:54Z","timestamp":1785488274008,"version":"3.56.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>ST-segment elevation myocardial infarction (STEMI) is a life-threatening condition needing urgent reperfusion, with better outcomes linked to optimal myocardial perfusion. Statins may reduce ischemia-reperfusion injury through pleiotropic effects. While the 2019 European Society of Cardiology (ESC) Dislipidemia Guidelines recommended high-intensity statins before percutaneous coronary intervention (PCI), this was not included in the 2023 ESC or 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI ACS Guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the effect of high-dose statin loading before primary PCI in improving coronary reperfusion and clinical outcomes in STEMI patients through a systematic review and meta-analysis of randomized controlled trials (RCTs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>On June 2025, CENTRAL, EMBASE, and PubMed were searched for RCTs comparing high-dose statin preloading with placebo or no statin in STEMI patients undergoing primary PCI. The primary outcome was post-PCI thrombolysis in myocardial infarction (TIMI) flow grade 3. Secondary outcomes included all-cause mortality and greater than or equal to 50% ST-segment resolution. Data were pooled using random-effects models, reporting odds ratios (OR) with 95% confidence intervals (CIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nine RCTs with 1862 patients were included. High-dose statin preloading significantly increased the likelihood of achieving post-PCI TIMI flow grade 3 (OR: 1.52, 95% CI: 1.06\u20132.20). It was also associated with a reduction in all-cause mortality (OR: 0.59, 95% CI: 0.36\u20130.98). No significant difference was observed in greater than or equal to 50% ST-segment resolution (OR: 1.04, 95% CI: 0.71\u20131.50).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>High-dose statin loading before primary PCI in STEMI patients seems to be associated with improved coronary reperfusion and reduced all-cause mortality. These findings offer timely and clinically relevant insight, reminding the cardiovascular community of the potential value of this therapeutic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mca.0000000000001629","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:00:51Z","timestamp":1773043251000},"page":"439-448","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the benefits of high-dose statin preloading in ST-segment elevation myocardial infarction management: insights from a systematic review and meta-analysis"],"prefix":"10.1097","volume":"37","author":[{"given":"Bernardo","family":"Resende","sequence":"first","affiliation":[{"name":"Cardiology Department, Unidade Local de Sa\u00fade de Coimbra, Coimbra"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Em\u00eddio","family":"Mata","sequence":"additional","affiliation":[{"name":"Cardiology Department, Unidade Local de Sa\u00fade Alto Ave, Guimar\u00e3es"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"Carlos","sequence":"additional","affiliation":[{"name":"Cardiology Department, Unidade Local de Sa\u00fade de Coimbra, Coimbra"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Portugu\u00eas","sequence":"additional","affiliation":[{"name":"Cardiology Department, Unidade Local de Sa\u00fade Alto Ave, Guimar\u00e3es"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Cardiology Department, Unidade Local de Sa\u00fade Alto Ave, Guimar\u00e3es"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Gameiro","sequence":"additional","affiliation":[{"name":"Cardiology Department, Unidade Local de Sa\u00fade de Coimbra, Coimbra"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Louren\u00e7o","sequence":"additional","affiliation":[{"name":"Cardiology Department, Unidade Local de Sa\u00fade Alto Ave, Guimar\u00e3es"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lino","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Cardiology Department, Unidade Local de Sa\u00fade de Coimbra, Coimbra"},{"name":"Faculdade de Medicina da Universidade de Coimbra"},{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"R1-20260731","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC).","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"R2-20260731","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","article-title":"European Society of Cardiology: cardiovascular disease statistics 2021.","volume":"43","author":"Timmis","year":"2022","journal-title":"Eur Heart J"},{"key":"R3-20260731","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/eurheartj\/ehi810","article-title":"Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients.","volume":"27","author":"Boersma","year":"2006","journal-title":"Eur Heart J"},{"key":"R4-20260731","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","article-title":"Myocardial no-reflow in humans.","volume":"54","author":"Niccoli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R5-20260731","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cvr\/cvz301","article-title":"Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction.","volume":"116","author":"Konijnenberg","year":"2020","journal-title":"Cardiovasc Res"},{"key":"R6-20260731","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/01.CIR.99.15.1945","article-title":"Relationship between TIMI frame count and clinical outcomes after thrombolytic administration.","volume":"99","author":"Gibson","year":"1999","journal-title":"Circulation"},{"key":"R7-20260731","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1536\/ihj.16-448","article-title":"Impact of postprocedural TIMI flow on long-term clinical outcomes in patients with acute myocardial infarction five year follow-up results in the Korea-AMI registry.","volume":"58","author":"Kim","year":"2017","journal-title":"Int Heart J"},{"key":"R8-20260731","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jacc.2003.11.042","article-title":"Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty.","volume":"43","author":"De Luca","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R9-20260731","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/heartjnl-2024-324078","article-title":"Intracoronary thrombolysis in ST-elevation myocardial infarction: a systematic review and meta-analysis.","volume":"110","author":"Rehan","year":"2024","journal-title":"Heart"},{"key":"R10-20260731","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10557-019-06901-0","article-title":"Pathophysiology, diagnosis, and management of the no-reflow phenomenon.","volume":"33","author":"Allencherril","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"key":"R11-20260731","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000131517.20177.5a","article-title":"Beneficial cardiovascular pleiotropic effects of statins.","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"R12-20260731","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system.","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ Res"},{"key":"R13-20260731","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.CIR.100.2.178","article-title":"Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts.","volume":"100","author":"Lefer","year":"1999","journal-title":"Circulation"},{"key":"R14-20260731","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jacc.2007.02.025","article-title":"Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.","volume":"49","author":"Patti","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R15-20260731","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.3390\/jcm11175142","article-title":"Comparison of the treatment efficacy of rosuvastatin versus atorvastatin loading prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction.","volume":"11","author":"Adel","year":"2022","journal-title":"J Clin Med"},{"key":"R16-20260731","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00380-015-0773-y","article-title":"Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial).","volume":"31","author":"Shimomura","year":"2016","journal-title":"Heart Vessels"},{"key":"R17-20260731","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/FJC.0b013e31829be05b","article-title":"Protection by atorvastatin pretreatment in patients undergoing primary percutaneous coronary intervention is associated with the lower levels of oxygen free radicals.","volume":"62","author":"Chen","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"R18-20260731","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ahj.2011.08.011","article-title":"Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.","volume":"162","author":"Hahn","year":"2011","journal-title":"Am Heart J"},{"key":"R19-20260731","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS).","volume":"41","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"key":"R20-20260731","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"R21-20260731","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R22-20260731","first-page":"756","article-title":"Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo\u2010controlled pilot trial.","volume":"80","author":"Post","year":"2012","journal-title":"Cathet Cardiovasc Interv"},{"key":"R23-20260731","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.clinthera.2013.01.009","article-title":"Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.","volume":"35","author":"Liu","year":"2013","journal-title":"Clin Ther"},{"key":"R24-20260731","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.amjcard.2014.03.059","article-title":"Efficacy of early intensive rosuvastatin therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (ROSEMARY Study).","volume":"114","author":"Ko","year":"2014","journal-title":"Am J Cardiol"},{"key":"R25-20260731","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jama.2018.2444","article-title":"Effect of loading dose of atorvastatin prior to planned percutaneous coronary intervention on major adverse cardiovascular events in acute coronary syndrome: the SECURE-PCI randomized clinical trial.","volume":"319","author":"Berwanger","year":"2018","journal-title":"JAMA"},{"key":"R26-20260731","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.arcmed.2018.10.006","article-title":"Reduction of no reflow with a loading dose of atorvastatin before primary angioplasty in patients with acute ST myocardial infarction.","volume":"49","author":"Garc\u00eda-M\u00e9ndez","year":"2018","journal-title":"Arch Med Res"},{"key":"R27-20260731","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jacc.2005.03.077","article-title":"Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.","volume":"46","author":"Ray","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R28-20260731","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"R29-20260731","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12944-015-0095-1","article-title":"Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials.","volume":"14","author":"Pan","year":"2015","journal-title":"Lipids Health Dis"},{"key":"R30-20260731","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.12659\/MSM.911921","article-title":"Effect of high-dose statin pretreatment for myocardial perfusion in patients receiving percutaneous coronary intervention (PCI): a meta-analysis of 15 randomized studies.","volume":"24","author":"Xiao","year":"2018","journal-title":"Med Sci Monit"},{"key":"R31-20260731","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.amjcard.2014.02.034","article-title":"Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.","volume":"113","author":"Navarese","year":"2014","journal-title":"Am J Cardiol"},{"key":"R32-20260731","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s12872-023-03402-9","article-title":"A systematic review and meta-analysis of the effect of high-intensity statin on coronary microvascular dysfunction.","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"R33-20260731","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1161\/01.CIR.0000147778.05979.E6","article-title":"Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction.","volume":"110","author":"Schr\u00f6der","year":"2004","journal-title":"Circulation"},{"key":"R34-20260731","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/jamacardio.2018.3408","article-title":"Timing of loading dose of atorvastatin in patients undergoing percutaneous coronary intervention for acute coronary syndromes: insights from the SECURE-PCI randomized clinical trial.","volume":"3","author":"Lopes","year":"2018","journal-title":"JAMA Cardiol"},{"key":"R35-20260731","doi-asserted-by":"crossref","first-page":"528","DOI":"10.14503\/THIJ-14-4891","article-title":"Intensive statin therapy in NSTE-ACS patients undergoing PCI: clinical and biochemical effects.","volume":"42","author":"Shehata","year":"2015","journal-title":"Tex Heart Inst J"},{"key":"R36-20260731","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCRESAHA.118.312782","article-title":"Statin toxicity.","volume":"124","author":"Ward","year":"2019","journal-title":"Circ Res"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:01:19Z","timestamp":1785484879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001629","relation":{},"ISSN":["0954-6928","1473-5830"],"issn-type":[{"value":"0954-6928","type":"print"},{"value":"1473-5830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"2025-10-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}